Skip to main content

Table 1 Baseline characteristics in patients with poor and good collateral

From: Predictor of poor coronary collaterals in chronic kidney disease population with significant coronary artery disease

Variables Poor collateral Good collateral P value
(n = 122) (n = 80)
Age (years) 68.1 ± 10.1 65.7 ± 12.0 0.146
Gender (Female, %) 37.7 25.0 0.067
DM (%) 56.6 43.8 0.085
HTN (%) 82 63.8 0.005
Smoking (%) 50 42.5 0.316
BMI 25.0 ± 4.0 25.5 ± 3.6 0.351
eGFR (mL/min/1.73 m2) 40.7 ± 16.5 40.3 ± 16.0 0.853
Previous events of ACS (%) 68 58.8 0.229
Laboratory data    
Hemoglobin (g/dl) 12.2 ± 2.3 12.2 ± 2.6 1.000
Cholesterol (mg/dl) 198.5 ± 41.8 212.4 ± 67.8 0.104
Triglyceride (mg/dl) 187.7 ± 142.3 168.6 ± 138.1 0.360
Uric acid (mg/dl) 7.1 ± 2.2 6.9 ± 2.0 0.713
Medication    
Anti-platelet (%) 43.4 51.3 0.314
ACEI (%) 19.8 21.3 % 0.855
ARB (%) 21.6 24.0 0.725
Beta blocker (%) 30.8 34.7 0.636
Nitrate (%) 24.8 30.7 0.407
CCB (%) 25 17.3 0.283
Diuretic (%) 21.6 24.0 0.725
Statin (%) 18.6 27.6 0.159
  1. ACEI: angiotensin converting enzyme inhibitor; ACS: acute coronary syndrome; ARB: angiotensin II receptor blocker; BMI: body mass index; CCB: calcium channel blocker; DM: diabetes; HTN: hypertension; eGFR: estimated glomerular filtration rate.